US Expansion IRBM has opened a Boston office and shows active engagement at major industry events, signaling growing capability to support US and European partners and collaborate on early discovery programs and regional operations.

Integrated Discovery With a single unified research facility and an in-house oncology pipeline, IRBM enables concept-to-candidate work within one organization, helping partners accelerate discovery milestones and reduce handoffs.

Platform Capabilities IRBM's platform strengths include phage and mRNA display and a track record of collaboration with MSD, positioning the company as a platform partner for discovery programs and potential licensing or co-development opportunities in peptide therapeutics.

Strategic Partnerships IRBM's history of collaborations and scalable operations suggest strong potential for strategic, long-term partnerships with large and mid-size pharma, with flexible engagement models and milestone-based deals to align with growing client pipelines.

Digital Compliance IRBM leverages a regulatory-ready tech stack including GDPR compliance and CRM integration, supporting secure, efficient collaboration and data governance across multi-site programs and clients.